Search results
Results from the WOW.Com Content Network
The OHSU Knight Cancer Institute (previously the OHSU Cancer Institute) is a research institute within Oregon Health & Science University. The National Cancer Institute (NCI) designated cancer center is led by director Tom Sellers. [1] [2] It is the only NCI-designated Comprehensive Cancer Center in the state of Oregon. [3]
Brian J. Druker, M.D. (born April 30, 1955) [1] is a physician-scientist and JELD-WEN Chair of Leukemia Research at Oregon Health & Science University in Portland, Oregon.He previously served as chief executive officer and director of OHSU's Knight Cancer Institute, [2] [3] [4] as well as Associate Dean for Oncology in the OHSU School of Medicine.
Owen McCarty is an American biomedical engineer who studies the dynamics of the vascular system in the context of cancer metastasis, cardiovascular disease, and inflammation.
Lyman earned his B.A. in 1968 from the State University of New York at Buffalo, followed by a Doctor of Medicine degree in 1972 from the same institution. In 1974 he completed an internal medicine residency at the University of North Carolina in Chapel Hill and in 1977 completed his Medical Oncology and Hematology Fellowship at Roswell Park Memorial Institute.
The Willamette University School of Medicine, OHSU's earliest predecessor, was founded in the 1860s in Salem, and was relocated to Portland in the 1870s. [11] In 1915, Willamette University and the University of Oregon merged their medical programs to form the University of Oregon Medical School, and in 1919 the school moved to its present location on Marquam Hill in Southwest Portland.
Prasad has won several teaching awards, including the 2017 Craig Okada Award for best teacher in the Hematology Oncology Fellowship program, the 2018 faculty mentorship award from the internal medicine residency, the 2019 J. David Bristow award from the graduating medical students, and the 2020 excellence in research and scholarship mentoring ...
Andrew Louis Pecora (born 1957) is an American hematologist and oncologist involved in research on the use of stem cells and oncolytic viruses to treat diseases, including cancer. [1]
Tibor Jack Greenwalt (January 23, 1914 – July 17, 2005) was an American hematologist who specialized in transfusion medicine.Greenwalt earned his medical degree from New York University Medical School in 1937 and completed a hematology fellowship under William Dameshek.